- Report
- January 2026
- 477 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 175 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 576 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 268 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 376 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 276 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 380 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 568 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 281 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 395 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 281 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 469 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 287 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 359 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 281 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 368 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 369 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 390 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 486 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 276 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more